What's New In Digital Health

As the rates of skin cancer cases continues to rise at an annual rate of 7.7%, dermatologists, GPs and other medical professionals are unable to meet the growing need for detecting this disease at the earliest possible stage for optimized health outcomes.

DermEngine, an intelligent dermatology platform, can support this demand through increasing the accessibility, efficiency, and quality of provided services through features such as  its teledermatology feature, clinical decision support tools, communications network, and cross-platform accessibility.

Introduction

Nearly two-thirds of dermatology practices in the U.S. serve an abundance of patients suffering from general dermatology cases. In addition to this backlog of patient cases for general concerns, one in five Americans are projected to be diagnosed with a form of skin cancer within their lifetime. To overcome these life-threatening burdens, patients must be able to quickly receive fast, accessible, and quality care from their healthcare provider to promote the early detection of skin cancer and achieve sustainable positive care outcomes. Unfortunately, in many areas this fails to be the case, with wait times of over 60 days.

Below are DermEngine’s solutions to current problems overwhelming dermatology systems: accessibility, efficiency, and quality. For each challenge, the platform applies the latest technology in artificial intelligence (AI) designed to adapt to a variety of scenarios while streamlining everyday dermatology and primary care workflows.

-The MetaOptima Team

To continue reading, download the full version: